Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2015 Leerink Global Healthcare Conference
February 05, 2015 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will present, via "fireside chat"...
Sucampo Appoints And
Sucampo Appoints Andrew Smith, FCMA, CGMA as CFO
January 30, 2015 16:02 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the appointment of Andrew Smith, FCMA, CGMA...
AMITIZA(R) (lubipros
AMITIZA(R) (lubiprostone) Mutual Recognition Procedure Closes With Recommendation for Approval in European Countries
January 30, 2015 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the successful completion of the European...
Robert J. Spiegel, M
Robert J. Spiegel, M.D., FACP Joins Sucampo's Board of Directors
January 21, 2015 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Robert J. Spiegel, M.D., FACP has...
Sucampo Announces Ac
Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada
December 30, 2014 17:00 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Dec. 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Health Canada has accepted the...
Sucampo Appoints Joh
Sucampo Appoints John H. Johnson to Board of Directors
December 15, 2014 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Dec. 15, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the appointment of John H. Johnson, founder,...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 26th Annual Piper Jaffray Healthcare Conference
November 25, 2014 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Files Patent
Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's
November 12, 2014 17:31 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd., Takeda Pharmaceutical...
Sucampo Pharmaceutic
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Stifel 2014 Healthcare Conference
November 11, 2014 06:45 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces Th
Sucampo Announces Third Quarter 2014 Financial Results
November 06, 2014 06:45 ET | Sucampo Pharmaceuticals Inc
Strong Revenue and Sales Growth for AMITIZA Raises 2014 Earnings Guidance, Excluding Special Items CEO Peter Greenleaf to Provide Update on Significant Progress Against Strategic Plan...